Inogen Inc (INGN)
9.05
-0.16
(-1.74%)
USD |
NASDAQ |
Nov 22, 09:44
Inogen Total Assets (Quarterly): 306.17M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 306.17M |
June 30, 2024 | 308.92M |
March 31, 2024 | 315.60M |
December 31, 2023 | 326.19M |
September 30, 2023 | 343.70M |
June 30, 2023 | 374.35M |
March 31, 2023 | 385.67M |
December 31, 2022 | 405.04M |
September 30, 2022 | 469.58M |
June 30, 2022 | 470.07M |
March 31, 2022 | 474.62M |
December 31, 2021 | 489.51M |
September 30, 2021 | 512.86M |
June 30, 2021 | 498.17M |
March 31, 2021 | 476.48M |
December 31, 2020 | 461.85M |
September 30, 2020 | 460.33M |
June 30, 2020 | 458.12M |
March 31, 2020 | 459.12M |
December 31, 2019 | 447.34M |
September 30, 2019 | 444.73M |
June 30, 2019 | 403.77M |
March 31, 2019 | 388.20M |
Date | Value |
---|---|
December 31, 2018 | 375.90M |
September 30, 2018 | 357.11M |
June 30, 2018 | 332.64M |
March 31, 2018 | 299.88M |
December 31, 2017 | 275.07M |
September 30, 2017 | 269.84M |
June 30, 2017 | 251.23M |
March 31, 2017 | 227.63M |
December 31, 2016 | 214.05M |
September 30, 2016 | 194.79M |
June 30, 2016 | 182.79M |
March 31, 2016 | 168.40M |
December 31, 2015 | 161.31M |
September 30, 2015 | 157.47M |
June 30, 2015 | 157.20M |
March 31, 2015 | 148.46M |
December 31, 2014 | 140.08M |
September 30, 2014 | 137.15M |
June 30, 2014 | 145.47M |
March 31, 2014 | 135.51M |
December 31, 2013 | 82.40M |
September 30, 2013 | 60.86M |
December 31, 2012 | 47.59M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
306.17M
Minimum
Sep 2024
512.86M
Maximum
Sep 2021
422.18M
Average
458.62M
Median
Total Assets (Quarterly) Benchmarks
Boston Scientific Corp | 38.08B |
ResMed Inc | 7.222B |
NovaBay Pharmaceuticals Inc | 3.877M |
Palatin Technologies Inc | 3.415M |
iBio Inc | 24.52M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 120.77M |
Shareholders Equity (Quarterly) | 185.40M |
Current Ratio | 2.660 |